Evidence map›Paper›PMID 24161279›Full record

ArticleNeuroscience2014

Modeling nigrostriatal degeneration in organotypic cultures, a new ex vivo model of Parkinson's disease.

N Daviaud, E Garbayo, N Lautram, F Franconi, L Lemaire, M Perez-Pinzon, C N Montero-Menei

Abstract read
In one paragraph

Article in Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Mechanical Forces Guide Axon Growth through the Nigrostriatal Pathway in an Organotypic Model.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. A Bridge BetweenNoro psikiyatri arsivi · 2020
    Review
  7. The Aqueous Extract fromAntioxidants (Basel, Switzerland) · 2020
    Article
  8. Frontiers in cell and developmental biology · 2020
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

N DaviaudLUNAM University, Angers University, France; INSERM UMR S_1066, Angers University, France.
E GarbayoLUNAM University, Angers University, France; INSERM UMR S_1066, Angers University, France; Pharmacy and Pharmaceutical Technology Department, University of Navarra, Pamplona, Spain.
N LautramLUNAM University, Angers University, France; INSERM UMR S_1066, Angers University, France.
F FranconiCIFAB-PRIMEX, LUNAM University, Angers University, France.
L LemaireLUNAM University, Angers University, France; INSERM UMR S_1066, Angers University, France.
M Perez-PinzonUniversity of Miami, Miller School of Medicine, Miami, FL, USA.
C N Montero-MeneiLUNAM University, Angers University, France; INSERM UMR S_1066, Angers University, France. Electronic address: claudia.montero-menei@univ-angers.fr.
Université d'Angers · FRInserm · FRUniversity of Miami · US

Funding

MECHANISMS OF NEUROPROTECTION AGAINST CARDIAC ARRESTR01NS045676 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PEREZ-PINZON, MIGUEL A · 2004 to 2024
$5.1M
NINDS NIH HHS R01 NS045676
6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most frequent neurodegenerative disorder afflicting 2% of the population older than 65 years worldwide. Recently, brain organotypic slices have been used to model neurodegenerative disorders, including PD. They conserve brain three-dimensional architecture, synaptic connectivity and its microenvironment. This model has allowed researchers a simple and rapid method to observe cellular interactions and mechanisms. In the present study, we developed an organotypic PD model from rat brains that includes all the areas involved in the nigrostriatal pathway in a single slice preparation, without using neurotoxins to induce the dopaminergic lesion. The mechanical transection of the nigrostriatal pathway obtained during slice preparation induced PD-like histopathology. Progressive nigrostriatal degeneration was monitored combining innovative approaches, such as diffusion tensor magnetic resonance imaging (DT-RMI) to follow fiber degeneration and mass spectrometry to quantify striatal dopamine content, together with bright-field and fluorescence microscopy imaging. A substantia nigra dopaminergic cell number decrease was observed by immunohistochemistry against rat tyrosine hydroxylase (TH) reaching 80% after 2 days in culture associated with a 30% decrease of striatal TH-positive fiber density, a 15% loss of striatal dopamine content quantified by mass spectrometry and a 70% reduction of nigrostriatal fiber fractional anisotropy quantified by DT-RMI. In addition, a significant decline of medium spiny neuron density was observed from days 7 to 16. These sagittal organotypic slices could be used to study the early stage of PD, namely dopaminergic degeneration, and the late stage of the pathology with dopaminergic and GABAergic neuron loss. This novel model might improve the understanding of PD and may represent a promising tool to refine the evaluation of new therapeutic approaches.

Indexed as

Disease Models, AnimalAnimalsAnimals, NewbornCorpus StriatumDiffusion Tensor ImagingDopamineFemaleHumansMass SpectrometryMedial Forebrain BundleNeural PathwaysNeurodegenerative DiseasesOrgan Culture TechniquesPhosphopyruvate HydratasePregnancyRatsDopaminePhosphopyruvate HydrataseTyrosine 3-Monooxygenase6-hydroxydopamine6-OHDAbovine serum albuminBSADARPP32diffusion tensor imagingdiffusion tensor magnetic resonance imagingdopaminedopamine- and cAMP-regulated neuronal phosphoproteinDT-RMIFAfractional anisotropyH(2)O(2)Hank’sHank’s Balanced Salt Solutionhydrogen peroxideIgGimmunoglobulin GLC–MS/MSliquid chromatography–mass spectrometrymagnetic resonance imagingmass spectrometrymedial forebrain bundlemedium spiny neuronMEMMFBMinimum Essential Medium EagleMRIMSNNeuNneuronal nucleiNGSnigrostriatal organotypic slicesnormal goat serumParkinson’s diseasePBSPBSTPDphosphate-buffered salinephosphate-buffered saline containing 1% Tritonrapid acquisition with relaxation enhancementRAREreactive oxygen speciesROSSNsubstantia nigraTHtyrosine hydroxylase

Identifiers

PMID24161279
PMCPMC4104532
OpenAlexW2044273528

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.